Mast Cell Protease 5 Inhibitors represent a category of chemical compounds designed to modulate the activity of Mast Cell Protease 5 (MCPT5), an enzyme predominantly found within mast cells. These inhibitors play a vital role in research and drug development by targeting the enzymatic function of MCPT5, which is responsible for the cleavage of various protein substrates involved in inflammation and immune responses. By selectively interacting with MCPT5, these inhibitors aim to influence cellular processes related to mast cell function, with the goal of elucidating the mechanisms underlying mast cell activation and degranulation.
The development and study of MCPT5 inhibitors involve a diverse range of chemical structures and mechanisms of action, reflecting the complexity of mast cell biology. Researchers have sought to identify compounds that can bind to MCPT5's active site, thereby preventing its proteolytic activity. These inhibitors may work through competitive or non-competitive mechanisms, either reversibly or irreversibly. Some compounds within this class may belong to broader categories like serine protease inhibitors, as MCPT5 is a serine protease itself. Understanding the structure-activity relationships of MCPT5 inhibitors is crucial for designing molecules with optimal specificity and potency while minimizing off-target effects. Ultimately, the study of Mast Cell Protease 5 Inhibitors contributes to a deeper comprehension of mast cell function and the intricate processes involved in allergic and immune responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Gabexate mesylate is a synthetic serine protease inhibitor that targets MCPT5 by binding to its active site, preventing its enzymatic activity and thereby reducing the release of inflammatory mediators. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Nafamostat mesylate is a serine protease inhibitor that can inhibit MCPT5 activity by binding to its active site, leading to a reduction in mast cell activation and inflammatory responses. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF hydrochloride is a reversible serine protease inhibitor that can target MCPT5 by binding to its active site, inhibiting its proteolytic activity, and thereby reducing mast cell degranulation. | ||||||
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
Benzamidine is a reversible serine protease inhibitor that can inhibit MCPT5 by competing with its substrates for binding to the enzyme's active site, suppressing mast cell activation. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a serine protease inhibitor that can inhibit MCPT5 by binding to its active site, blocking its enzymatic activity, and reducing the release of inflammatory mediators. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
Camostat mesylate is a serine protease inhibitor that targets MCPT5 by blocking its active site, thereby inhibiting mast cell activation and inflammatory responses. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a cysteine protease inhibitor that may indirectly affect MCPT5 activation by modulating intracellular protease activity, leading to reduced mast cell degranulation. | ||||||
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
Batimastat is a matrix metalloproteinase (MMP) inhibitor that can indirectly impact MCPT5 activation by affecting the extracellular matrix remodeling associated with mast cell-mediated inflammation. | ||||||